Literature DB >> 31109474

Prevalence of suspected glaucoma in Haiti: a pilot study.

Nicolas Cadet1, Taylor Nayman2, Paul Harasymowycz1.   

Abstract

OBJECTIVE: Gather epidemiological data pertaining to the prevalence of suspected glaucoma in rural and urban areas of Haiti.
DESIGN: Cross-sectional pilot study. PARTICIPANTS: Haitians of African ancestry.
METHODS: We conducted a cross-sectional study on 211 Haitians of African ancestry (76 males and 135 females) aged 40 years and over. The mean age was 54.6 ± 10.9 years. The data were collected in glaucoma screening clinics at health fairs held in urban Port-au-Prince (57 people) and three rural regions (154 people) during a two-week medical mission to Haiti in November 2014. An ophthalmic exam with intraocular pressure measurement (with Tonopen) and dilated fundus exam were conducted.
RESULTS: The average C/D was 0.41 ± 0.18. The prevalence of suspected glaucoma, defined as C/D ≥ 0.7, asymmetry of ≥0.2 or significant rim notching, was 14.2%. The average IOP was 18.4 ± 5.4. Ocular hypertension (IOP ≥ 24mmHg) was found in 19.0% of participants.
CONCLUSIONS: The prevalence of ocular hypertension and glaucoma based on suspect optic nerves in our sample population was high, indicating a strong need for access to ophthalmologic care in the Haitian population.
Copyright © 2018 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 31109474     DOI: 10.1016/j.jcjo.2018.06.001

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  1 in total

1.  Glaucoma Cascade Screening in a High Risk Afro-Caribbean Haitian Population: A Pilot Study.

Authors:  Ta C Chang; Linda Celestin; Elizabeth A Hodapp; Alana L Grajewski; Anna Junk; Adam L Rothman; Eric R H Duerr; Swarup S Swaminathan; Steven J Gedde; Terri L Young; Janey Wiggs; Mildred M G Olivier; Raquel Quintanilla; Esdras Arrieta; Eleonore J Savatovsky; Elizabeth A Vanner; Richard K Parrish
Journal:  J Glaucoma       Date:  2022-02-08       Impact factor: 2.290

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.